GURenal cancer Episode 11: The efficacy of belzutifan on PFS and ORR in metastatic ccRCC: Litespark-005 15 April 2024
GURenal cancer Episode 8: Rechallenging with immune checkpoint inhibitors does not benefit mRCC patients after progression 11 March 2024
GURenal cancer The KEYNOTE-564 trial: the first evidence for the benefit of immunotherapy in high risk clear cell RCC patients 21 February 2024
